Dow Chemical the No. 1 US chemical maker by sales, reported a higher-than-expected adjusted profit as cost cutting ratcheted up margins to their highest in more than a decade.
Dow has been clearing the decks ahead of its $130 billion merger with traditional rival DuPont by slashing administration costs and laying off employees.
The deal, due to close later this year, is the first step toward breaking the businesses into three separate companies focused on agriculture, material science and specialty products.
The merger is expected to create cost synergies of about $3 billion, the companies have said.
However, Dow’s chief financial officer, Howard Ungerleider, indicated on Thursday that further cost savings were likely.
“We feel very good that $3 billion in synergies we announced in December is a floor, not a ceiling,” he told Reuters.
Dow plans to slash costs by $300 million this year. Of that, $90 million was cut in the first quarter, Ungerleider said.
Dow’s strategy to focus on high-margin products by shedding volatile commodity businesses such as its century-old chlorine business has also been paying off.
“We see strong demand signals in North America, gradual recovery in Europe and ongoing sustainable urbanization in China,” Chief Executive Andrew Liveris said in a statement announcing the company’s first-quarter results.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI